Strengthening the Medical Device Assembly Business Through Proprietary Joining Technology
First written in FY2019. 13 of 21 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2027-H1.
1 other company's latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「In the MD business, sales to the venture ecosystem, in which the company participates as a manufacturing partner, remained sluggish. However, sales of catheter components and unit products to major domestic medical device manufacturers, its principal customers, remained solid, resulting in revenue above the prior-year period.」
In the MD business, sales to the venture ecosystem remained sluggish, while sales of catheter components and unit products to major medical device manufacturers remained solid, driving a 19.7% year-on-year increase in segment revenue. - FY2026AdvancedAnnual report
「In the MD business, we are promoting the development and commercialization of advanced medical devices in the neurosurgical field through collaboration with domestic companies, while preparations for the commercialization of products developed in-house have entered full swing following the acquisition of a Class I medical device marketing business license.」
In the MD business, we obtained a Class I medical device marketing business license, making concrete preparations for the development and commercialization of advanced medical devices in the neurosurgical field and for products developed in-house. - FY2026-H1Sales to the MD venture ecosystem struggled to grow, while sales to key customers remained steady.Annual report
「In the MD business, sales to the venture ecosystem in which we participate as a manufacturing partner struggled to grow, but sales of catheter components and unit products to major domestic medical device manufacturers, our key customers, remained steady, and sales exceeded the same period of the previous year.」
In the MD business, sluggish sales to the venture ecosystem coexisted with steady sales of catheter components and units to major domestic medical device manufacturers. - FY2025AdvancedAnnual report
「In the MD business, sales exceeded the previous fiscal year, owing to increased sales of catheter components and units to major domestic medical device manufacturers, our key customers, as well as steady sales to the venture ecosystem in which we participate as a manufacturing partner.」
In the MD business, sales to the venture ecosystem remained steady in addition to sales of components and units to key customers, and revenue in the FC and MD segment increased 31.8% from the previous fiscal year. - FY2025-H1AdvancedAnnual report
「In the MD business, sales exceeded the same period of the previous year, owing to increased sales of catheter components and units to major domestic medical device manufacturers, our key customers, as well as steady sales to the venture ecosystem in which we participate as a manufacturing partner.」
In the MD business, sales of catheter components and units to major domestic medical device manufacturers, as well as sales to the venture ecosystem in which we participate as a manufacturing partner, remained steady. - FY2024RaisedAnnual report
「① Launching internally planned products based on authorization to manufacture and market medical devices ② Accelerating contributions to humanity and society by expanding the ecosystem in the advanced medical-device field」
The MD business has been positioned as the fourth core business, and the initiatives have been expanded to include the launch of internally planned products based on authorization to manufacture and market medical devices, as well as expansion of the advanced medical ecosystem. - FY2024-Q2AdvancedAnnual report
「In the MD business, orders for catheter components from major domestic medical-device manufacturers increased, while unit-product sales also remained solid, resulting in revenue above the year-earlier level.」
In the MD business, orders for catheter components from major domestic medical-device manufacturers increased, unit-product sales remained solid, and revenue exceeded the year-earlier level. - FY2024-Q1AdvancedAnnual report
「In the MD business included in this segment, sales of catheter components to major domestic medical-device manufacturers, the company's major customers, remained solid, among other factors, resulting in revenue above the previous fiscal year's level.」
In the MD business, sales of catheter components to major domestic medical-device manufacturers exceeded the previous fiscal year's level. - FY2023-Q3RestatedAnnual report
「In the Medical Devices business included in this segment, sales of components to major customers remained solid, among other factors, resulting in revenue above the year-earlier level.」
In the Medical Devices business, sales of components to major customers remained solid, and revenue exceeded the year-earlier level. - FY2023-Q2AdvancedAnnual report
「In the Medical Devices business included in this segment, sales of both components and unit products to major customers remained solid, among other factors, resulting in revenue above the year-earlier level. Consequently, segment revenue increased to ¥4,989 million, up 8.8% year on year.」
In the Medical Devices business, sales of components and unit products to major customers were both solid, and revenue in the Wireless Communications Equipment segment increased 8.8% year on year. - FY2022RaisedAnnual report
「Medical Devices business: Contributing to social development alongside business expansion by building a development-focused OEM supplier and venture ecosystem in advanced medical fields」
The scope has been expanded from strengthening the proprietary joining technology and assembly business to becoming a development-focused OEM supplier and building a venture ecosystem. - FY2022-Q3AdvancedAnnual report
「In the Medical Devices business included in this segment, overall orders remained weak due to the impact of COVID-19, but sales of new unit products were improving, resulting in revenue above the year-earlier level.」
Despite weak overall orders, sales of new unit products in the Medical Devices business were improving, and revenue exceeded the year-earlier level. - FY2022-Q2Component sales below the previous year, while unit-product sales remained solidAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid and the decline in component sales was beginning to ease as pressure on medical facilities subsided. However, this was not enough to offset the first-quarter revenue decline, and revenue fell below the year-earlier level.」
In the Medical Devices business, unit-product sales remained solid and the decline in component sales was beginning to ease, but this did not offset the first-quarter revenue decline, leaving revenue below the year-earlier level. - FY2022-Q1Decline in component sales offset by solid unit-product salesAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid, but component sales declined due to pressure on medical facilities, among other factors, resulting in revenue below the year-earlier level. Consequently, segment revenue was ¥2,437 million, up 13.2% year on year. Segment profit was ¥447 million, down 11.1% year on year, due to a lower sales mix of relatively high-margin products in the Fine Connectors business and lower profit accompanying the decline in revenue in the Medical Devices business.」
In the Medical Devices business, component sales declined due to pressure on medical facilities, while sales of unit products remained solid. Revenue in the overall Wireless Communications Equipment segment increased 13.2%, but profit decreased 11.1%. - FY2021Decline in component orders offset by solid sales of new unit productsAnnual report
「In the Medical Devices business included in this segment, component orders decreased due to the impact of COVID-19, but sales of new unit products remained solid, resulting in revenue at the same level as in the previous fiscal year.」
While component orders decreased due to the pandemic, sales of new unit products remained solid, and revenue in the Wireless Communications Equipment business, including Medical Devices, increased 11.1% year on year. - FY2021-Q2AdvancedAnnual report
「In the Medical Devices business included in this segment, component orders remained weak due to the impact of COVID-19, but sales of new unit products remained strong, resulting in revenue exceeding the year-earlier level. Consequently, segment revenue increased to ¥4,808 million, up 10.6% year on year.」
Despite weak component orders, sales of new unit products in the Medical Devices business remained strong, and revenue in the Wireless Communications Equipment segment increased 10.6% year on year. - FY2020AdvancedAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid in both Japan and overseas, while component sales also increased, resulting in a substantial increase in revenue from the previous fiscal year. Consequently, segment revenue increased to ¥8,498 million, up 14.4% year on year.」
Sales of unit products and components in the Medical Devices business increased, and revenue in the Wireless Communications Equipment segment rose 14.4% year on year. - FY2020-Q3AdvancedAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid in both Japan and overseas, while component sales also increased, resulting in a year-on-year increase in revenue. Consequently, segment revenue increased to ¥6,489 million, up 15.5% year on year. Segment profit was ¥1,537 million, up 14.6% year on year, due to profit growth from higher revenue, a higher proportion of relatively high-margin products and improved yield in the Medical Devices business.」
Sales of unit products and components increased in the Medical Devices business, and yield also improved. Revenue in the Wireless Communications Equipment segment increased 15.5%, and profit increased 14.6%. - FY2020-Q2AdvancedAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid in both Japan and overseas, while component sales also increased, resulting in a substantial year-on-year increase in revenue. Consequently, segment revenue increased substantially year on year to ¥4,349 million, up 19.5%. Segment profit was ¥1,089 million, up 39.7% year on year, due to profit growth from higher revenue, a higher proportion of relatively high-margin products and improved yield in the Medical Devices business.」
Sales of unit products and components increased in the Medical Devices business, and yield also improved. Revenue in the Wireless Communications Equipment segment increased 19.5%, and profit increased 39.7%. - FY2020-Q1AdvancedAnnual report
「In the Medical Devices business included in this segment, sales of unit products remained solid in both Japan and overseas, while component sales also increased, resulting in a substantial year-on-year increase in revenue. Consequently, segment revenue increased substantially year on year to ¥2,153 million, up 24.5%. Segment profit was ¥525 million, up 71.3% year on year, due to profit growth from higher revenue, a higher proportion of relatively high-margin products and improved yield in the Medical Devices business.」
Sales of unit products and components increased in the Medical Devices business, and yield also improved. Across the Wireless Communications Equipment segment, revenue increased 24.5% year on year and profit increased 71.3%. - FY2019First statedAnnual report
「③ Strengthening the assembly business for medical devices through proprietary joining technology, among other initiatives」
As a product innovation initiative under the new medium-term management plan, the company has identified for the first time the strengthening of its assembly business through proprietary joining technology. It also plans to expand production capacity and launch mass production of new assembly products.